Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for ...

Roy Sutton passed away in March while in the middle of three projects. JPR revisits his 2024 conversation with "My Better Half" host Vanessa Finney.

Global business visionary, inventor, and philanthropist leaves behind a legacy of improving billions of lives around the ...

Prepare to unleash your creativity and productivity with the newest member of the moto g family in North America: the moto g stylus - 2025. Featuring an improved built-in stylus, a durable yet stylish ...

GoPro, Inc. ("GoPro" or "Company") is pleased to announce the appointment of Mick Lopez to GoPro's Board of Directors, ...

Researchers at Ben-Gurion University of the Negev have developed a machine-learning algorithm that could enhance our ...

In a new study published in Developmental Cell on April 8, a research team led by Prof. WU Qingfeng at the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences has ...

The cells with electrophysiological activity obtained at the University of the Basque Country (UPV/EHU) are opening up new avenues for the study of neurodegenerative diseases and the development of ...

The National Minority Quality Forum (NMQF) proudly announces the 2025 theme for National Minority Health Month: “Health Unlocked: Access, Alignment, Action.” This year’s theme recognizes the evolving ...

Scientists have attempted to map the human cell since the first microscope was invented more than 400 years ago. But many ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

By mapping the subcellular architecture and protein interactions within cells, researchers can better understand how mutations contribute to pediatric cancers and other conditions.